1 Min Read
Feb 8 (Reuters) - Theraclion SA:
* Announces First Patients Treated In U.S. Pivotal Multicentre FDA Study Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.